Last reviewed · How we verify
SPD476 (1.2g)
SPD476 is a small molecule drug that targets the molecular target.
SPD476 is a small molecule drug that targets the molecular target. Used for Unknown.
At a glance
| Generic name | SPD476 (1.2g) |
|---|---|
| Also known as | Lialda, MMX™ mesalazine |
| Sponsor | Shire |
| Drug class | Unknown |
| Target | Unknown |
| Modality | Small molecule |
| Therapeutic area | Unknown |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action of SPD476 is not well understood, but it is believed to work by modulating the activity of the molecular target. This leads to a cascade of downstream effects that ultimately result in the therapeutic effect.
Approved indications
- Unknown
Common side effects
- Unknown
Key clinical trials
- Prevention of Recurrence of Diverticulitis (PHASE3)
- Prevention of Recurrence of Diverticulitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |